CryoCell International Correlations
CCEL Stock | USD 6.37 0.21 3.19% |
The current 90-days correlation between CryoCell International and Oncology Institute is 0.16 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CryoCell International moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CryoCell International moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
CryoCell International Correlation With Market
Modest diversification
The correlation between CryoCell International and DJI is 0.25 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding CryoCell International and DJI in the same portfolio, assuming nothing else is changed.
CryoCell |
Moving together with CryoCell Stock
0.64 | XAIR | Beyond Air | PairCorr |
0.77 | INFU | InfuSystems Holdings | PairCorr |
0.64 | LIVN | LivaNova PLC | PairCorr |
0.76 | NVST | Envista Holdings Corp | PairCorr |
0.66 | OFIX | Orthofix Medical | PairCorr |
0.72 | CLPT | Clearpoint Neuro | PairCorr |
Moving against CryoCell Stock
0.37 | KIDS | Orthopediatrics Corp | PairCorr |
0.75 | MNDR | Mobile health Network | PairCorr |
0.66 | OCX | OncoCyte Corp | PairCorr |
0.53 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
0.47 | GSK | GlaxoSmithKline PLC ADR | PairCorr |
0.44 | SNY | Sanofi ADR | PairCorr |
0.42 | NVS | Novartis AG ADR | PairCorr |
0.33 | GILD | Gilead Sciences Sell-off Trend | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between CryoCell Stock performing well and CryoCell International Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze CryoCell International's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
NHC | 1.32 | (0.40) | 0.00 | (0.69) | 0.00 | 2.19 | 7.80 | |||
INNV | 2.59 | (0.42) | 0.00 | (0.51) | 0.00 | 5.44 | 27.64 | |||
PNTG | 2.02 | (0.25) | 0.00 | (0.47) | 0.00 | 3.67 | 15.62 | |||
EHC | 1.11 | 0.06 | 0.05 | 0.05 | 1.38 | 2.15 | 6.49 | |||
AIH | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
AIRS | 4.27 | (0.97) | 0.00 | (0.89) | 0.00 | 7.93 | 27.83 | |||
AVAH | 3.37 | 0.36 | 0.09 | 0.26 | 3.60 | 6.17 | 40.55 | |||
TOI | 7.85 | 3.35 | 0.46 | 0.97 | 5.05 | 21.95 | 38.02 | |||
BKD | 1.90 | 0.27 | 0.11 | 0.23 | 2.06 | 4.83 | 12.23 | |||
SGRY | 1.74 | 0.25 | 0.14 | 0.28 | 1.71 | 3.39 | 23.37 |
CryoCell International Corporate Executives
Elected by the shareholders, the CryoCell International's board of directors comprises two types of representatives: CryoCell International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CryoCell. The board's role is to monitor CryoCell International's management team and ensure that shareholders' interests are well served. CryoCell International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CryoCell International's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jill Taymans | CFO and VP of Fin. | Profile |